-
Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS TrialsM Konigstein, PC Smits, MP Love et al. -
Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of MorbidityKhan SS, Ning H, Wilkins JT et al.
-
Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and CostKwok CS, Rao SV, Potts JE et al.
-
Coronary Angiography after Cardiac Arrest without ST-Segment ElevationLemkes JS, Janssens GN, van der Hoeven NW et al.
-
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart FailureYancy CW, Jessup M, Bozkurt B et al.
-
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)Roffi M, Patrono C, ESC Scientific Document Group.
-
Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA studyJansen H, Jänsch A, Koenig W et al.
-
Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT GuidelinesY Ueki, A Karagiannis, C Zanchin et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
